Page 4 - Flow Cytometry Protocols Fourth Edition
P. 4

Contributors



        LAURIE  E.  AILLES  •  Princess Margaret Cancer Centre,  University Health Network,  Toronto,
           ON,  Canada
        C.  BRUCE  BAGWELL  •  Verity Software House,  Topsham, ME,  USA
        DAVID  BRYDER  •  Division of  Molecular Hematology,  Institution for Laboratory Medicine,
           Lund  University,  Lund,  Sweden
        ALEXIS N.  CONWAY  •  Roswell Park Cancer Institute,  Buffalo,  NY,  USA
        ERIKA  DUGGAN  •  Scintillon Institute,  San Die0,  CA,  USA
        ADOLFAS  K.  GAIGALAS  •  National Institute  of  Standards and Technology  (NIST),
           Gaithersburg,  MD,  USA
        DAVID W.  GALBRAITH  •  School of  Plant Sciences,  Bio5 Institute,  University of  Arizona,
           Tucson, AZ,  USA
        JOCHEN  GUCK  •  Biotechnology Center,  Technische  Universit~t Dresden,  Dresden,  Germany
        MAIK HERBIG  •  Biotechnology Center,  Technische  Univ»ersit~t  Dresden,  Dresden,  Germany
        JESSICA P.  HOUSTON  •  Department of  Chemical & Materials Engineering,  New Mexico State
           University, Las Cruces,  NM,  USA
        JAMES W.  JACOBBERGER  •  Case  Comprehensive Cancer Center,  Case  Western Reserve
           University,  Cleveland,  OH,  USA
        MARTIN  KRATER  •  Universit~tsklinikum Carl Gusta  Carus,  Technische  Universit~t  Dresden,
           Dresden,  Germany
        WENYAN  LI  •  Department of  Chemical &: Materials Engineering,  New Mexico State
           University,  Las Cruces,  NM,  USA
        DONGXIA  LIN  •  Fluidim Corporation,  South San Francisco,  CA,  USA
        PATRICIA  LOVELACE  •  Human Immune Monitoring Center,  Institute for Immunity,
           Transplantation,  and Infection,  Stanford  University,  Stanford,  CA,  USA
        PAUL M~LLER  •  Biotechnology Center,  Technische  Universit~t Dresden,  Dresden,  Germany
        HOLDEN  T.  MAECKER  •  Human Immune Monitoring Center,  Institute for Immunity,
           Transplantation,  and Infection,  Stanford  University School of  Medicine,  Stanford,  CA,
           USA
        KATHERINE  M.  MCKINNON  •  Vaccine Branch Flow»  Cytometry Facility,  Center for Cancer
           Research,  National Cancer Institute,  National Institutes of  Health,  Bethesda, MD,  USA
        KATHARINE A.  MUIRHEAD  •  SciGro,  Inc., Middleton,  WI,  USA
        PETER NAGY  •  Department of  Biophysics and Cell Biology,  Faculty of  Medicine,  University of
           Debrecen,  Debrecen,  Hungary
        KAPIL NICHANI  •  Department of  Chemical & Materials Engineering,  New Mexico State
           University,  Las Cruces,  NM,  USA
        JOHN P.  NOLAN  •  Scintillon Institute,  San Die0,  CA,  USA
        MAURICE R.G.  OGORMAN  •  Department of  Pathology and Pediatrics,  Children's Hospital of
           Los Angeles and the Keck School of  Medicine,  University of  Southern California,
           Los Angeles,  CA,  USA
        OLIVER OTTO  •  Zentrum fur Innovationskompetenz: Humorale Immunreaktionen bei
           Kardioaskul~ren Erkrankungen,  Universit~t Greifswald,  Greifswald,  Germany
        JOSHUA PATERSON  •  Princess Margaret Cancer Centre,  University Health Network,  Toronto,
           ON,  Canada

                                               xii'
   1   2   3   4   5   6   7   8   9